Article info
PDFResearch ethics
Paper
Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. An observational study to evaluate patient's informed consent comprehension
- Correspondence to Virginia Sanchini, Department of Experimental Oncology, European Institute of Oncology (IEO), IFOM-IEO Campus, Via Adamello 16, Milan 20139, Italy; virginia.sanchini{at}ieo.eu
Citation
Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. An observational study to evaluate patient's informed consent comprehension
Publication history
- Received September 24, 2012
- Revised March 25, 2013
- Accepted April 18, 2013
- First published May 31, 2013.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- 620 Creating a culture of clinical research in the clinic: Integrating clinical trials into the care of patients with lupus
- Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis
- Understanding potential participation barriers to improve trial design and outcomes: clinical trial simulation in palmoplantar pustulosis as a case study
- Clinical trial participation and aggressive care at the end of life in patients with ovarian cancer
- Engaging African ancestry participants in SLE clinical trials
- End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care
- Off-trial access to experimental cancer agents for the terminally ill: balancing the needs of individuals and society
- Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
- Phase I oncology trials: why the therapeutic misconception will not go away
- Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision